The Medicines Company - Recothrom, PreveLeak and Raplixa's Unit Acquisition

The Medicines Company - Recothrom, PreveLeak and Raplixa raised a round of funding on December 18, 2015. Investors include Mallinckrodt.

The Medicines company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. The company's…

Articles about The Medicines Company - Recothrom, PreveLeak and Raplixa's Unit Acquisition: